pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

American Cancer Society cancels wine and spirits gala amid conflict-of-interest concerns

Aug 20, 2026·read at STAT ↗Neutral

The American Cancer Society announced it will not hold the planned Wine and Spirits Industry Gala after internal review highlighted a conflict of interest with the alcohol sector, which is linked to cancer risk.

The decision comes after reporting revealed the society had received at least $22 million over several years from wine and liquor executives, raising questions about the appropriateness of the partnership.

In the same newsletter, the team noted recent coverage of Moderna and Merck’s mRNA cancer vaccine efforts and pointed readers to a 2016 Sharon Begley story on personalized cancer vaccines as a background resource.

The update was part of STAT’s Morning Rounds briefing, which also tracks legal developments in gender-affirming care and other health policy topics.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Contrasting legal decisions on gender-affirming care”

read at STAT ↗
1,098 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.2UNIQUEUltragenyx Pharmaceutical Inc.
topics
Oncology11Vaccine3Psychiatry & CNS2Vaccines2mRNA Therapeutic2OphthalmologyRare DiseaseSmall Molecule

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 1d agoKolon TissueGene cuts 37 US staffers after Phase 3 failBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Abcuro secures $66M; InduPro assembles $77MFierce Biotech
  • Jul 1FDA says Zyn can market its pouches as safer than cigarettesSTAT
  • May 13Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?STAT